Drug details
Corifact (factor xiii concentrate (human) lyophilized powder reconstitution for intravenous use)
type of
Corifact is a Factor XIII concentrate indicated for adult and pediatric patients with congenital Factor XIII deficiency for routine prophylactic treatment
and peri-operative management of surgical bleeding.
This drug may have the following side effects:
- itching
- rash
- joint inflammation
- hypersensitivity
- redness
- swelling of blood clots (hematoma)
- joint pain
- headache
- chills
- fever
-
acute ischemia - neutralizing antibodies against FXIII
The following drugs are related to Corifact, either as a replacement or used together:
- Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
- Adynovate (antihemophilic factor (recombinant), pegylated for injection)
- Feiba VH (anti-inhibitor coagulant complex, vapor heated)
- Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
- Bebulin VH (factor ix complex intravenous administration)
- BeneFIX (coagulation factor ix recombinant for injection)
- Coagadex (coagulation factor x lyophilized powder)
- Profilnine (factor ix complex intravenous administration)
- Octaplas (pooled plasma (human) solvent/detergent)